This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Addition of China's Zhipu to US entity list to hit international cooperation

By MLex Staff ( January 17, 2025, 07:34 GMT | Insight) -- The addition of Chinese artificial intelligence company Zhipu to the US export-control list indicates the double-edged effect of its closeness to the Chinese government, with the likelihood that it will have an impact on business confidence and international cooperation. Zhipu AI, formally known as Beijing Zhipu Huazhang Technology, and its subsidiaries were recently added to the US Commerce Department's Bureau of Industry and Security's entity list for allegedly advancing China's military modernization through the development and integration of advanced artificial intelligence research. The addition of Chinese artificial intelligence company Zhipu to the US export-control list indicates a double-edged effect of its closeness to the Chinese government, with the likelihood that it will have an impact on business confidence and international cooperation....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections